BHC
Income statement / Annual
Last year (2024), Bausch Health Companies Inc.'s total revenue was $9.63 B,
an increase of 9.91% from the previous year.
In 2024, Bausch Health Companies Inc.'s net income was -$46.00 M.
See Bausch Health Companies Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$9.63 B |
$8.76 B |
$8.12 B |
$8.43 B |
$8.03 B |
$8.60 B |
$8.38 B |
$8.72 B |
$9.67 B |
$10.44 B |
| Cost of Revenue |
$2.78 B
|
$2.56 B
|
$2.36 B
|
$2.39 B
|
$2.25 B
|
$2.35 B
|
$2.35 B
|
$2.55 B
|
$2.57 B
|
$2.45 B
|
| Gross Profit |
$6.84 B
|
$6.20 B
|
$5.76 B
|
$6.04 B
|
$5.78 B
|
$6.25 B
|
$6.03 B
|
$6.18 B
|
$7.10 B
|
$8.00 B
|
| Gross Profit Ratio |
0.71
|
0.71
|
0.71
|
0.72
|
0.72
|
0.73
|
0.72
|
0.71
|
0.73
|
0.77
|
| Research and Development Expenses |
$634.00 M
|
$604.00 M
|
$530.00 M
|
$473.00 M
|
$485.00 M
|
$516.00 M
|
$442.00 M
|
$369.00 M
|
$469.00 M
|
$440.00 M
|
| General & Administrative Expenses |
$2.50 B
|
$2.27 B
|
$2.01 B
|
$1.98 B
|
$1.92 B
|
$2.01 B
|
$1.99 B
|
$2.12 B
|
$2.22 B
|
$2.05 B
|
| Selling & Marketing Expenses |
$786.00 M
|
$625.00 M
|
$518.00 M
|
$515.00 M
|
$451.00 M
|
$544.00 M
|
$481.00 M
|
$462.00 M
|
$564.00 M
|
$652.00 M
|
| Selling, General & Administrative Expenses |
$3.28 B
|
$2.90 B
|
$2.53 B
|
$2.49 B
|
$2.37 B
|
$2.55 B
|
$2.47 B
|
$2.58 B
|
$2.78 B
|
$2.70 B
|
| Other Expenses |
$1.38 B
|
$1.74 B
|
$2.25 B
|
$2.63 B
|
$2.25 B
|
$3.38 B
|
$5.50 B
|
$3.12 B
|
$4.42 B
|
$3.33 B
|
| Operating Expenses |
$5.30 B
|
$5.24 B
|
$5.31 B
|
$5.59 B
|
$5.10 B
|
$6.45 B
|
$8.41 B
|
$6.07 B
|
$7.67 B
|
$6.47 B
|
| Cost And Expenses |
$8.08 B
|
$7.79 B
|
$7.67 B
|
$7.98 B
|
$7.35 B
|
$8.80 B
|
$10.76 B
|
$8.62 B
|
$10.24 B
|
$8.92 B
|
| Interest Income |
$33.00 M
|
$26.00 M
|
$14.00 M
|
$7.00 M
|
$13.00 M
|
$12.00 M
|
$11.00 M
|
$12.00 M
|
$8.00 M
|
$3.30 M
|
| Interest Expense |
$1.39 B
|
$1.33 B
|
$1.46 B
|
$1.43 B
|
$1.53 B
|
$1.61 B
|
$1.69 B
|
$1.84 B
|
$1.84 B
|
$1.56 B
|
| Depreciation & Amortization |
$1.27 B
|
$1.26 B
|
$1.39 B
|
$1.55 B
|
$1.83 B
|
$2.08 B
|
$2.82 B
|
$2.86 B
|
$2.87 B
|
$2.47 B
|
| EBITDA |
$3.13 B |
$2.89 B |
$2.88 B |
$3.26 B |
$3.14 B |
$3.42 B |
$3.32 B |
$3.41 B |
$4.07 B |
$5.11 B |
| EBITDA Ratio |
0.33
|
0.33
|
0.35
|
0.39
|
0.39
|
0.4
|
0.4
|
0.39
|
0.42
|
0.49
|
| Operating Income Ratio |
0.16
|
0.11
|
0.06
|
0.05
|
0.08
|
-0.02
|
-0.28
|
0.01
|
-0.06
|
0.15
|
| Total Other Income/Expenses Net |
-$1.38 B
|
-$1.35 B
|
-$583.00 M
|
-$1.47 B
|
-$1.61 B
|
-$1.63 B
|
-$1.77 B
|
-$1.84 B
|
-$1.87 B
|
-$1.68 B
|
| Income Before Tax |
$167.00 M
|
-$390.00 M
|
-$129.00 M
|
-$1.02 B
|
-$934.00 M
|
-$1.84 B
|
-$4.15 B
|
-$1.74 B
|
-$2.44 B
|
-$155.00 M
|
| Income Before Tax Ratio |
0.02
|
-0.04
|
-0.02
|
-0.12
|
-0.12
|
-0.21
|
-0.5
|
-0.2
|
-0.25
|
-0.01
|
| Income Tax Expense |
$239.00 M
|
$221.00 M
|
$83.00 M
|
-$87.00 M
|
-$375.00 M
|
-$54.00 M
|
-$10.00 M
|
-$4.15 B
|
-$27.00 M
|
$133.00 M
|
| Net Income |
-$46.00 M
|
-$592.00 M
|
-$225.00 M
|
-$948.00 M
|
-$559.00 M
|
-$1.78 B
|
-$4.15 B
|
$2.40 B
|
-$2.41 B
|
-$268.66 M
|
| Net Income Ratio |
-0
|
-0.07
|
-0.03
|
-0.11
|
-0.07
|
-0.21
|
-0.49
|
0.28
|
-0.25
|
-0.03
|
| EPS |
-0.13 |
-1.62 |
-0.59 |
-2.61 |
-1.57 |
-5.06 |
-11.86 |
8.63 |
-6.94 |
-0.78 |
| EPS Diluted |
-0.13 |
-1.62 |
-0.59 |
-2.61 |
-1.57 |
-5.06 |
-11.86 |
8.59 |
-6.94 |
-0.77 |
| Weighted Average Shares Out |
$368.00 M
|
$365.43 M
|
$362.00 M
|
$358.90 M
|
$355.00 M
|
$352.10 M
|
$349.87 M
|
$350.20 M
|
$347.12 M
|
$342.70 M
|
| Weighted Average Shares Out Diluted |
$368.00 M
|
$364.90 M
|
$362.00 M
|
$358.90 M
|
$355.00 M
|
$352.10 M
|
$349.87 M
|
$351.80 M
|
$347.30 M
|
$347.30 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
